STEPHANIE STAHL: Open Payments
NPI 1790175792 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,219 in 89 payments from 15 companies in 2025. Trend: 2023 $303 · 2024 $346 · 2025 $2,219
Food & beverage: $1,784Travel & lodging: $324Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $854 |
| Neurocrine BioSciences, Inc. | 20 | $515 |
| LivaNova USA, Inc. | 1 | $324 |
| Teva Pharmaceuticals USA, Inc. | 5 | $194 |
| MDD US Operations, LLC | 2 | $71 |
| Biogen, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $33 |
| SK Life Science, Inc. | 1 | $30 |
| UCB, Inc. | 1 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
Products named: INGREZZA, UBRELVY, QULIPTA, VNS Therapy, BOTOX, AUSTEDO XR, Gocovri, REXULTI.
Industry payments across CA — which companies pay providers there.
